Bayer Commits $5.6 Billion to Glyphosate Alternatives Amid 13,000 Lawsuits Over the WeedkillerThe move is seen as an olive branch to critics of the Roundup weedkiller, which is accused of causing cancer.
Bayer CEO Faces a Shareholder Reckoning Over the Monsanto DealThey says he should've foreseen the risks of acquiring Monsanto's Roundup weedkiller, which is accused of causing cancer.
Roche Bids $4.8 Billion for U.S.-Based Gene Therapy Specialist SparkPurchasing Philadelphia-based Spark will help Roche to compete with Basel-based neighbor Novartis AG in developing the new area of medicine
1 - 3 of 3 results
1 - 3 of 3 results
